子宮頸發育不良市場：依診斷類型、最終使用者、地區

子宮頸發育不良市場規模預計將從 2023 年的 6.75 億美元增至 2030 年的 11.054 億美元，預測期內年複合成長率(CAGR)為 7.3%。

圖 1. 2023 年子宮頸發育不良市場佔有率(%)（按地區）

子宮頸發育不良是子宮頸內壁（子宮入口）細胞的癌前變化。這些變化是透過對骨盆檢查期間從子宮頸採集的細胞樣本進行顯微鏡分析來檢測的。鱗狀上皮內病變是從子宮頸細胞抹片中觀察到的子宮頸發育不良的病理學術語。子宮頸發育不良是由人類乳突病毒（HPV）感染引起的。 HPV 是一種非常常見的感染疾病，透過性接觸傳染。大多數新的 HPV 感染發生在年輕女性（15 至 25 歲）。大多數 HPV感染疾病沒有任何症狀並會自行消失。

市場動態：

主要市場參與者增加有機策略預計將在預測期內推動市場成長。例如，2021 年 3 月 1 日，專注於將精確設計的去氧核糖核酸（DNA）藥物推向市場，用於治療和預防感染疾病、癌症和 HPV 相關疾病的生物技術公司 Inovio 宣布 REVEAL 宣佈在一項研究中所有可評估受試者均實現了主要和次要終點。本研究使用我們專有的 CELLECTRA 5PSP 設備評估了 VGX-3100 對與 HPV-16/18 相關的子宮頸惡性鱗狀上皮內病變(HSIL) 的安全性、耐受性和有效性。它是兩項正在進行的、關鍵的、隨機的、雙盲、多中心、安慰劑對照 3 期試驗評估

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
• 政府加大力度
• 子宮頸發育不良的盛行率在全球範圍內不斷增加
  • 抑制因素
• 開發中國家缺乏認知
  • 機會
• 政府資助增加
• 主要亮點
• 監管場景
• 最近的趨勢
• 產品發布/核准
• PEST分析
• 波特的分析
• 合併、收購和合作

第4章子宮頸發育不良市場－冠狀病毒（COVID-19）大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章子宮頸發育不良市場，依診斷類型，2018-2030

• 診斷測試
• HPV檢測
• 子宮頸抹片檢查
• 切片檢查測試
• 診斷設備
• 陰道鏡檢查

第 6 章 子宮頸發育不良市場，依最終使用者分類，2018-2030 年

• 醫院
• 診斷中心
• 門診手術中心

第7章子宮頸發育不良市場，依地區，2018-2030

• 北美洲
• 美國
• 加拿大
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• ASEAN
• 韓國
• 其他亞太地區
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第8章 競爭形勢

• 公司簡介
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

第9章 章節

• 參考
• 調查方法
• 關於出版商

The Cervical Dysplasia Market size is expected to reach US$ 1,105.4 Mn by 2030, from US$ 675 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.3% during the forecast period.

Figure 1. Cervical Dysplasia Market Share (%), By Region, 2023

Cervical dysplasia is precancerous changes of the cells that make up the lining of the cervix, the opening to the womb (uterus). These changes are detected by microscopic analysis of cell samples which are taken from the cervix during a pelvic exam. Squamous intraepithelial lesion is the pathology term that is used to refer to cervical dysplasia which is observed in smears of cells taken from the cervix. Cervical dysplasia is caused by infection with the human papillomavirus (HPV). HPV is a very common infection that is transmitted through sexual contact. Most new HPV infections occur in young (ages 15-25) women. Most HPV infections do not produce any symptoms and resolve spontaneously.

Market Dynamics:

Increasing organic strategies by the key market players is expected to drive the market growth over the forecast period. For instance, on March 1, 2021, INOVIO, a biotechnology company focused on bringing to market precisely designed deoxyribonucleic acid (DNA)medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, announced that it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of two ongoing pivotal, randomized, double-blind, multi-center, placebo-controlled, Phase 3 trials evaluating the safety, tolerability, and efficacy of VGX-3100 to treat HPV-16/18-associated cervical high-grade squamous intraepithelial lesions (HSIL) using the company's proprietary CELLECTRA 5PSP device.

Cervical Dysplasia Market Detailed Segmentation:

• By Diagnosis Type
  • Diagnosis Test
  • HPV Test
  • Pap Smear Test
  • Biopsy Test
  • Diagnostic Device
  • Colposcope
• By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top Companies in Cervical Dysplasia Market:
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Diagnosis Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing government initiatives
• Growing prevalence of cervical dysplasia globally
  • Restraints
• Lack of awareness in developing nations
  • Opportunities
• Increasing government funding
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions and Collaborations

4. Cervical Dysplasia Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Cervical Dysplasia Market, By Diagnosis Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Diagnosis Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• HPV Test
• Pap Smear Test
• Biopsy Test
• Diagnostic Device
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Colposcope

6. Cervical Dysplasia Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Cervical Dysplasia Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• China
• Japan
• India
• Australia
• ASEAN
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
• South Africa
• North Africa
• Central Africa

8. Competitive Landscape

• Company Profile
  • Roche
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical
  • Analyst Views

9. Section

• References
• Research Methodology
• About us